MedTrace Logo

Efficacy and Safety of MEDITOXIN® in Cervical Dystonia

NCT03905304 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2019-04-08

No results posted yet for this study

Summary

The purpose of this study is to test the hypothesis that the efficacy and safety of Meditoxin® are not inferior to Botox®'s in the treatment of Cervical Dystonia.

Conditions

  • Cervical Dystonia

Interventions

BIOLOGICAL

Medytoxin

Intramuscular injection up to 300U.

BIOLOGICAL

Botox

Intramuscular injection up to 300U.

Sponsors & Collaborators

  • Medy-Tox

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-09
Primary Completion
2014-07-30
Completion
2014-08-05

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03905304 on ClinicalTrials.gov